Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Cory L. Grand
Observed names:
C. Grand,
C.L. Grand,
Cory Grand,
Cory L Grand
Observed institutions:
University of Arizona,
University of Saskatchewan,
Sumitomo Dainippon Pharma (United States),
SuperGen (United States),
University of Arizona Cancer Center,
Ludwig-Maximilians-Universität München
show all 6
ORCID:
0009-0007-4458-3745
Observed ORCID:
0009-0007-4458-3745
OpenAlex ID:
A5035230765
Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c- MYC transcription
2002
·
Adam Siddiqui-Jain
, Cory L. Grand
, et al.
·
Proceedings of the National Academy of Sciences
·
2,240
The cationic porphyrin TMPyP4 down-regulates c-MYC and human telomerase reverse transcriptase expression and inhibits tumor growth in vivo.
2002
·
Cory L Grand
, Haiyong Han
, et al.
·
PubMed
·
367
A valid ELISPOT assay for enumeration of ex vivo, antigen-specific, IFNγ-producing T cells
1999
·
Carl A Power
, Cory L Grand
, et al.
·
Journal of Immunological Methods
·
77
RETRACTED: Mutations in the G-quadruplex silencer element and their relationship to c-MYC overexpression, NM23 repression, and therapeutic rescue
2004
·
Cory L. Grand
, Tiffanie J. Powell
, et al.
·
Proceedings of the National Academy of Sciences
·
55
AXL Inhibition Improves the Antitumor Activity of Chimeric Antigen Receptor T Cells
2023
·
R. Leo Sakemura
, Mehrdad Hefazi
, et al.
·
Cancer Immunology Research
·
13
PDF
Retraction
2004
·
Cory L. Grand
, Tiffanie J. Powell
, et al.
·
Proceedings of the National Academy of Sciences
·
10
MP470 suppresses repair of double-strand breaks following treatment with DNA-damaging agents.
2007
·
Cory L. Grand
, Vatsala Naageshwaran
, et al.
·
Molecular Cancer Therapeutics
·
2
A small molecule inhibitor of Pim-1 kinase with activity in both hematological and solid tumor malignancies
2007
·
Jeremy Lamb
, Eric Gourley
, et al.
·
Molecular Cancer Therapeutics
·
2
414 POSTER Discovery and characterization of a small molecule inhibitor for pim-1 kinase
2006
·
D. Bearss
, C. Grand
, et al.
·
European Journal of Cancer Supplements
·
2
Targeting Pim Kinases in Hematological Malignancies.
2007
·
Eric S. Gourley
, Xiao-Hui Liu
, et al.
·
Blood
·
1
Discovery and development of MP529, a new effective and selective inhibitor of Aurora A kinase.
2007
·
Adrianne Clifford
, Cory L. Grand
, et al.
·
Cancer Research
·
1
341 POSTER The discovery of MP529, a potent and selective aurora kinase inhibitor using CLIMB
2006
·
H. Vankayalapati
, C. Grand
, et al.
·
European Journal of Cancer Supplements
·
1
413 POSTER Discovery and characterization of a series of Axl kinase inhibitors using the CLIMB process
2006
·
C. Grand
, H. Vankayalapati
, et al.
·
European Journal of Cancer Supplements
·
1
Supplementary Table S2 from AXL Inhibition Improves the Antitumor Activity of Chimeric Antigen Receptor T Cells
2025
·
R. Leo Sakemura
, Mehrdad Hefazi
, et al.
Supplementary Figure Legends from AXL Inhibition Improves the Antitumor Activity of Chimeric Antigen Receptor T Cells
2025
·
R. Leo Sakemura
, Mehrdad Hefazi
, et al.
Supplementary Figures from AXL Inhibition Improves the Antitumor Activity of Chimeric Antigen Receptor T Cells
2025
·
R. Leo Sakemura
, Mehrdad Hefazi
, et al.
Supplementary Table S1 from AXL Inhibition Improves the Antitumor Activity of Chimeric Antigen Receptor T Cells
2025
·
R. Leo Sakemura
, Mehrdad Hefazi
, et al.
Supplementary Table S1 from AXL inhibition improves the anti-tumor activity of chimeric antigen receptor T cells
2024
·
R. Leo Sakemura
, Mehrdad Hefazi
, et al.
Supplementary Table S2 from AXL inhibition improves the anti-tumor activity of chimeric antigen receptor T cells
2024
·
R. Leo Sakemura
, Mehrdad Hefazi
, et al.
Supplementary Figures from AXL inhibition improves the anti-tumor activity of chimeric antigen receptor T cells
2024
·
R. Leo Sakemura
, Mehrdad Hefazi
, et al.
Supplementary Table S1 from AXL inhibition improves the anti-tumor activity of chimeric antigen receptor T cells
2024
·
R. Leo Sakemura
, Mehrdad Hefazi
, et al.
Data from AXL inhibition improves the anti-tumor activity of chimeric antigen receptor T cells
2024
·
R. Leo Sakemura
, Mehrdad Hefazi
, et al.
Supplementary Figure Legends from AXL inhibition improves the anti-tumor activity of chimeric antigen receptor T cells
2024
·
R. Leo Sakemura
, Mehrdad Hefazi
, et al.
Supplementary Figure Legends from AXL inhibition improves the anti-tumor activity of chimeric antigen receptor T cells
2024
·
R. Leo Sakemura
, Mehrdad Hefazi
, et al.
Supplementary Table S2 from AXL inhibition improves the anti-tumor activity of chimeric antigen receptor T cells
2024
·
R. Leo Sakemura
, Mehrdad Hefazi
, et al.
Show more works
View as search
Works count:
53
Citation count:
2,772
H-index:
6
I10-index:
6
Year
Topic
Type
